60 Degrees Pharmaceuticals Inc. share price logo

60 Degrees Pharmaceuticals Inc.

NASDAQ: SXTP

Small Cap

$1.69

+0.01

(+0.60%)

as on

60 Degrees Pharmaceuticals Inc. Stock Performance

as on June 25, 2026 at 2:15 pm IST

  • Day's Low

    Day's High

    $1.65
    $1.70
    downward going graph

    2.37%

    Downside

    0.59%

    Upside

    downward going graph

  • 52 Week's Low

    52 Week's High

    $1.22
    $10.77
    downward going graph

    27.81%

    Downside

    537.35%

    Upside

    downward going graph

60 Degrees Pharmaceuticals Inc. share price movements today

Previous Close
$1.68
Open
$1.66
Volume
169.2K
Day's Low - High
$1.65 - $1.70
52 Week Low - High
$1.22 - $10.77

60 Degrees Pharmaceuticals Inc. Historical Returns

1 Month Return
+ 14.19 %
3 Month Return
+ 9.03 %
1 Year Return
-83.3 %
3 Year Return
0 %
5 Year Return
0 %

60 Degrees Pharmaceuticals Inc. Stock Fundamentals & Key Indicators

Check 60 Degrees Pharmaceuticals Inc. market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

$4.5M

EPS (TTM)

-3.45

Dividend Yield

0.00%

Quarterly Earnings Growth YOY

0.00%

PE Ratio (TTM)

0

PEG Ratio

0

EBITDA

-7.9M

Revenue (TTM)

1.3M

Profit Margin

0.00%

Return On Equity TTM

-172.82%

60 Degrees Pharmaceuticals Inc. vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of 60 Degrees Pharmaceuticals Inc. with its industry peers.

Company
Analyst View
Market Cap
5 Years Return %PE RatioProfit Margin %Dividend Yield %
60 Degrees Pharmaceuticals Inc. image
60 Degrees Pharmaceuticals Inc.
BUY$4.5MNANA0.00%NA
Alnylam Pharmaceuticals Inc. image
Alnylam Pharmaceuticals Inc.
BUY$38.5B67.66%72.4112.55%NA
Vertex Pharmaceuticals Inc. image
Vertex Pharmaceuticals Inc.
BUY$118.9B144.52%27.7835.51%NA
Regeneron Pharmaceuticals Inc. image
Regeneron Pharmaceuticals Inc.
BUY$64.8B13.24%15.0829.65%0.58%

Stock Returns calculator for 60 Degrees Pharmaceuticals Inc. Stock including INR - Dollar returns

The 60 Degrees Pharmaceuticals Inc. stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Impact: The bonus return you make when the US Dollar rises against the Rupee; calculated on the full amount you walk away with, not just what you invested in.

Investment Value

₹1,00,000

  • 1Y

60 Degrees Pharmaceuticals Inc. investment value today

Current value as on today

₹18,321

Returns

-₹81,679

(-81.68%)

Returns from 60 Degrees Pharmaceuticals Inc. Stock

-₹83,300 (-83.3%)

Dollar Impact

₹1,622 (+1.62%)

Analyst Recommendation on 60 Degrees Pharmaceuticals Inc. Stock

Based on 8 analysts

BUY

75.00%

Buy

25.00%

Hold

0.00%

Sell

Based on 8 analysts, 75% of analysts recommend a 'BUY' rating for 60 Degrees Pharmaceuticals Inc.. Average target price of $3.7

60 Degrees Pharmaceuticals Inc. Share Price Target

Get share price movements and forecasts by analysts on 60 Degrees Pharmaceuticals Inc..

What analysts predicted

54.32%UPSIDE

Target Price

$3.7

Current Price

$1.69

Analyzed by

8 Analysts

Target

$3.70

60 Degrees Pharmaceuticals Inc. target price $3.7, a slight upside of 54.32% compared to current price of $1.69. According to 8 analysts rating.

Indian Investors' Interest in 60 Degrees Pharmaceuticals Inc. Stock

Search interest for 60 Degrees Pharmaceuticals Inc. Stock has decreased by -39% in the last 30 days, reflecting a downward trend in search activity.

Time period: to

Change:-39% versus previous 30 day period

60 Degrees Pharmaceuticals Inc. Quarterly Profit & Loss

All numbers in Millions USD

Dec 2023
Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Total Revenue
0
0
0
0
0
0
0
0
0
0
Gross Profit
0
0
0
0
0
0
0
0
0
0
Operating Income
-1
-1
-4
-2
-2
-1
-1
-2
-1
-2
EBITDA
-1
0
-4
-2
-2
-1
-1
-2
-1
-2
Interest Expense
0
0
0
0
0
0
0
0
0
0
Depreciation
0
0
0
0
0
0
0
0
0
0
Income Before Tax
-2
0
-4
-2
-2
-1
-1
-2
-1
-2
Income Tax Expense
0
0
0
0
0
0
0
0
0
-
Net Income
-1
0
-4
-2
-2
-1
-1
-2
-1
-2
Net Profit Margin
-4584.98%
407.36%
-3338.95%
-1596.38%
-783.65%
-1147.37%
-1717.72%
-529.48%
-474.98%
-1289.49%

60 Degrees Pharmaceuticals Inc. Annual Profit & Loss

All numbers in Millions USD

Dec 2020
Dec 2021
Dec 2022
Dec 2023
Dec 2024
Dec 2025
Total Revenue
2
1
0
0
0
1
Gross Profit
1
0
0
0
0
0
Operating Income
0
-1
-1
-5
-9
-7
EBITDA
0
-1
-2
-1
-7
-7
Interest Expense
2
3
3
2
0
0
Depreciation
0
0
0
0
0
0
Income Before Tax
-3
-4
-6
-3
-7
-7
Income Tax Expense
0
0
0
0
0
-
Net Income
-3
-4
-6
-3
-7
-7
Net Profit Margin
-139.08%
-366.42%
-2769.49%
-1485.06%
-1308.01%
-732.82%

60 Degrees Pharmaceuticals Inc. Quarterly Cash Flow

All numbers in Millions USD

Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Net Income
0
-4
-2
-2
-1
-1
-2
-1
-2
Operating Cash Flow
-1
-1
-1
-1
-1
-1
-2
-1
-2
Investing Cash Flow
0
0
-1
0
1
0
0
-1
1
Financing Cash Flow
1
0
5
0
1
-
4
0
3
Change in Cash
0
-1
1
-1
1
-1
2
-2
1

60 Degrees Pharmaceuticals Inc. Annual Cash Flow

All numbers in Millions USD

Dec 2021
Dec 2022
Dec 2023
Dec 2024
Dec 2025
Net Income
-4
-6
-3
-7
-7
Operating Cash Flow
0
-1
-4
-5
-6
Investing Cash Flow
0
0
0
-1
0
Financing Cash Flow
0
1
6
7
6
Change in Cash
0
0
1
0
0

Global Institutional Holdings in 60 Degrees Pharmaceuticals Inc.

Funds
Holdings
Bank of America Corp
0%
Kathmere Capital Management, LLC
5.44%
Geode Capital Management, LLC
0.61%
DRW Securities, LLC
0%
TWIN PEAKS WEALTH ADVISORS LLC
0%
See all

Insights on 60 Degrees Pharmaceuticals Inc.

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

  • imgNO EFFECT

    Against Peers

    img

    In the last 1 year, Regeneron Pharmaceuticals, Inc. Common Stock has given 19.8% return, outperforming this stock by 103.1%

  • imgNEGATIVE IMPACT

    Profit Down

    img

    Netprofit is down for the last 2 quarters, -1.44M → -2.09M (in $), with an average decrease of 45.1% per quarter

  • imgNEGATIVE IMPACT

    Price Dip

    img

    In the last 1 year, SXTP stock has moved down by -83.3%

  • imgNEGATIVE IMPACT

    Revenue Fall

    img

    Revenue is down for the last 3 quarters, 437.60K → 162.09K (in $), with an average decrease of 38.6% per quarter

About 60 Degrees Pharmaceuticals Inc.

60 Degrees Pharmaceuticals, Inc., a specialty pharmaceutical company, engages in the development and commercialization of therapies for the prevention and treatment of infectious diseases in the United States. It offers Arakoda for malaria prevention treatment. The company also engages in the development of Tafenoquine (Arakoda regimen) that is in Phase IIb clinical trial for COVID-19 indications; Tafenoquine, which is in phase IIA clinical trials for babesiosis, fungal and pneumocystis pneumonias, and candidiasis disease; and Celgosivir for Zika, respiratory viruses, and dengue fever. It also has patent license agreement with Tufts Medical Center to jointly advance the development and commercialization of tafenoquine for the treatment and prevention of babesiosis. 60 Degrees Pharmaceuticals, Inc. was founded in 2010 and is headquartered in Washington, District Of Columbia.
Organisation60 Degrees Pharmaceuticals Inc.
Headquarters1025 Connecticut Avenue NW, Washington, DC, United States, 20036
IndustryBiotechnology
CEODr. Geoffrey Stuart Dow Ph.D.
E-voting on sharesClick here to vote

Key Management of 60 Degrees Pharmaceuticals Inc.

Name

Title

Dr. Geoffrey Stuart Dow Ph.D.

Chairman, CEO & President

Mr. Tyrone Miller

CFO & Treasurer

Ms. Kristen Landon

Chief Commercial Officer

Dr. Bryan Smith

Chief Medical Officer

FAQs

What is 60 Degrees Pharmaceuticals Inc. share price today?

60 Degrees Pharmaceuticals Inc. share price today is $1.69 as on at the close of the market. 60 Degrees Pharmaceuticals Inc. share today touched a day high of $1.7 and a low of $1.65.

What is the 52 week high and 52 week low for 60 Degrees Pharmaceuticals Inc. share?

60 Degrees Pharmaceuticals Inc. share touched a 52 week high of $10.77 on and a 52 week low of $1.22 on . 60 Degrees Pharmaceuticals Inc. stock price today i.e. is closed at $1.69,which is 84.31% down from its 52 week high and 38.52% up from its 52 week low.

What is 60 Degrees Pharmaceuticals Inc.'s market capitalisation today?

60 Degrees Pharmaceuticals Inc. market capitalisation is $0.00T as on .

How to invest in 60 Degrees Pharmaceuticals Inc. Stock (SXTP) from India?

  1. Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
  2. Step 2: Search for 60 Degrees Pharmaceuticals Inc. on INDmoney app. Click on Buy button. You can invest as low as $1.5 in 60 Degrees Pharmaceuticals Inc. Shares that will get you 0.8876 shares as per 60 Degrees Pharmaceuticals Inc. share price of $1.69 per share as on June 25, 2026 at 8:45 am IST.

What is the minimum amount required to buy 60 Degrees Pharmaceuticals Inc. Stock (SXTP) from India?

Indian investors can start investing in 60 Degrees Pharmaceuticals Inc. (SXTP) shares with as little as ₹94.395 or $1 (as of ) using the INDmoney app.
For example: If you want to invest $10 or ₹943.95 in 60 Degrees Pharmaceuticals Inc. stock (as per the Rupee-Dollar exchange rate as on ). Based on 60 Degrees Pharmaceuticals Inc. share’s latest price of $1.69 as on June 25, 2026 at 8:45 am IST, you will get 5.9172 shares of 60 Degrees Pharmaceuticals Inc.. Learn more about fractional shares .